A Post-Authorization Safety Study of Guillain-Barré Syndrome (GBS) Following ABRYSVOTM Among Older Adults in the United States (C3671031)

06/10/2025
08/05/2026
EU PAS number:
EUPAS1000000753
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C3671031_RSV VACCINE PROTOCOL AMENDMENT 4 V5.0_11SEP2024.pdf

English (746.46 KB - PDF) View document
Updated protocol

C3671031_RSV VACCINE PROTOCOL AMENDMENT 5 V6.0_15APR2026.pdf

First published: 06/05/2026
English (858.9 KB - PDF) View document
Study results
Study report
Other information